Asian Phytoceuticals Public Company Limited
Asian Phytoceuticals Public Company Limited engages in the research and development, manufacture, and distribution of healthcare and natural extracts-based beauty products in Thailand. The company offers cream and lotion products in bottles and tubes for massage to tighten the skin and reduce the desired area, and facial lotion products; and products for reverse aging, anti-aging, and longevity. … Read more
Asian Phytoceuticals Public Company Limited (APCO) - Net Assets
Latest net assets as of September 2025: ฿543.28 Million THB
Based on the latest financial reports, Asian Phytoceuticals Public Company Limited (APCO) has net assets worth ฿543.28 Million THB as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿609.19 Million) and total liabilities (฿65.91 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿543.28 Million |
| % of Total Assets | 89.18% |
| Annual Growth Rate | 9.39% |
| 5-Year Change | -6.0% |
| 10-Year Change | -1.49% |
| Growth Volatility | 24.09 |
Asian Phytoceuticals Public Company Limited - Net Assets Trend (2007–2024)
This chart illustrates how Asian Phytoceuticals Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Asian Phytoceuticals Public Company Limited (2007–2024)
The table below shows the annual net assets of Asian Phytoceuticals Public Company Limited from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ฿559.72 Million | -8.60% |
| 2023-12-31 | ฿612.39 Million | +0.31% |
| 2022-12-31 | ฿610.51 Million | +2.61% |
| 2021-12-31 | ฿594.99 Million | -0.08% |
| 2020-12-31 | ฿595.46 Million | +2.81% |
| 2019-12-31 | ฿579.19 Million | -5.69% |
| 2018-12-31 | ฿614.16 Million | -2.25% |
| 2017-12-31 | ฿628.31 Million | -3.20% |
| 2016-12-31 | ฿649.10 Million | +14.24% |
| 2015-12-31 | ฿568.18 Million | +10.32% |
| 2014-12-31 | ฿515.04 Million | +27.40% |
| 2013-12-31 | ฿404.28 Million | +7.14% |
| 2012-12-31 | ฿377.34 Million | +1.54% |
| 2011-12-31 | ฿371.61 Million | +99.87% |
| 2010-12-31 | ฿185.93 Million | +7.30% |
| 2009-12-31 | ฿173.29 Million | +22.20% |
| 2008-12-31 | ฿141.80 Million | +16.49% |
| 2007-12-31 | ฿121.73 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Asian Phytoceuticals Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 603.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿56.39 Million | 10.13% |
| Common Stock | ฿300.00 Million | 53.88% |
| Other Comprehensive Income | ฿30.00 Million | 5.39% |
| Other Components | ฿170.43 Million | 30.61% |
| Total Equity | ฿556.82 Million | 100.00% |
Asian Phytoceuticals Public Company Limited Competitors by Market Cap
The table below lists competitors of Asian Phytoceuticals Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aurumin Ltd
AU:AUN
|
$16.52 Million |
|
Halcyon Technology Public Company Limited
BK:HTECH
|
$16.53 Million |
|
Uniflex Technology Inc
TW:3321
|
$16.53 Million |
|
Berkosan Yalitim ve Tecrit Maddeleri Uretim ve Ticaret AS
IS:BRKSN
|
$16.53 Million |
|
SMT Scharf AG
XETRA:S188
|
$16.52 Million |
|
Daegu Dept Sto
KO:006370
|
$16.52 Million |
|
Jazz Resources Inc
PINK:JZRIF
|
$16.52 Million |
|
Z-Com Inc
TWO:8176
|
$16.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Asian Phytoceuticals Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 609,695,623 to 556,823,023, a change of -52,872,600 (-8.7%).
- Net income of 54,710,895 contributed positively to equity growth.
- Dividend payments of 107,928,288 reduced retained earnings.
- Other comprehensive income increased equity by 48,875,273.
- Other factors decreased equity by 48,530,480.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿54.71 Million | +9.83% |
| Dividends Paid | ฿107.93 Million | -19.38% |
| Other Comprehensive Income | ฿48.88 Million | +8.78% |
| Other Changes | ฿-48.53 Million | -8.72% |
| Total Change | ฿- | -8.67% |
Book Value vs Market Value Analysis
This analysis compares Asian Phytoceuticals Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.94x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.31x to 2.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | ฿0.83 | ฿2.76 | x |
| 2011-12-31 | ฿1.24 | ฿2.76 | x |
| 2012-12-31 | ฿0.80 | ฿2.76 | x |
| 2013-12-31 | ฿0.73 | ฿2.76 | x |
| 2014-12-31 | ฿0.99 | ฿2.76 | x |
| 2015-12-31 | ฿1.04 | ฿2.76 | x |
| 2016-12-31 | ฿1.17 | ฿2.76 | x |
| 2017-12-31 | ฿1.05 | ฿2.76 | x |
| 2018-12-31 | ฿1.02 | ฿2.76 | x |
| 2019-12-31 | ฿0.97 | ฿2.76 | x |
| 2020-12-31 | ฿0.99 | ฿2.76 | x |
| 2021-12-31 | ฿0.99 | ฿2.76 | x |
| 2022-12-31 | ฿1.01 | ฿2.76 | x |
| 2023-12-31 | ฿1.02 | ฿2.76 | x |
| 2024-12-31 | ฿0.94 | ฿2.76 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Asian Phytoceuticals Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.83%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 25.95%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 1.14x
- Recent ROE (9.83%) is below the historical average (16.76%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 14.16% | 14.30% | 0.82x | 1.21x | ฿5.89 Million |
| 2009 | 31.40% | 18.72% | 1.29x | 1.30x | ฿37.08 Million |
| 2010 | 23.81% | 17.31% | 1.18x | 1.17x | ฿25.67 Million |
| 2011 | 13.50% | 17.25% | 0.71x | 1.10x | ฿13.00 Million |
| 2012 | 14.77% | 19.49% | 0.68x | 1.12x | ฿18.00 Million |
| 2013 | 19.50% | 22.62% | 0.76x | 1.13x | ฿38.42 Million |
| 2014 | 23.06% | 27.89% | 0.76x | 1.09x | ฿67.26 Million |
| 2015 | 17.71% | 24.59% | 0.65x | 1.11x | ฿43.80 Million |
| 2016 | 20.25% | 31.19% | 0.59x | 1.10x | ฿66.51 Million |
| 2017 | 17.22% | 26.03% | 0.61x | 1.08x | ฿45.38 Million |
| 2018 | 15.43% | 25.62% | 0.56x | 1.08x | ฿33.33 Million |
| 2019 | 10.00% | 23.38% | 0.39x | 1.09x | ฿-14.93K |
| 2020 | 11.75% | 28.25% | 0.36x | 1.17x | ฿10.43 Million |
| 2021 | 11.55% | 30.76% | 0.33x | 1.14x | ฿9.20 Million |
| 2022 | 13.31% | 32.32% | 0.37x | 1.12x | ฿20.12 Million |
| 2023 | 17.63% | 36.72% | 0.42x | 1.16x | ฿46.52 Million |
| 2024 | 9.83% | 25.95% | 0.33x | 1.14x | ฿-971.41K |
Industry Comparison
This section compares Asian Phytoceuticals Public Company Limited's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $662,989,582
- Average return on equity (ROE) among peers: 37.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Asian Phytoceuticals Public Company Limited (APCO) | ฿543.28 Million | 14.16% | 0.12x | $16.52 Million |
| 88(Thailand) Public Company Limited (88TH) | $221.11 Million | 25.22% | 0.28x | $15.31 Million |
| Bangkok Lab & Cosmetic PCL (BLC) | $281.51 Million | 44.66% | 3.31x | $12.24 Million |
| Do Day Dream Public Company Limited (DDD) | $374.95 Million | 87.48% | 1.07x | $16.05 Million |
| Jack Chia Industries (Thailand) Public Company Limited (JCT) | $1.31 Billion | 6.77% | 0.23x | $6.30 Million |
| Karmarts Public Company Limited (KAMART) | $107.26 Million | 73.53% | 13.45x | $183.04 Million |
| Rojukiss International Public Company Limited (KISS) | $1.09 Billion | 12.03% | 0.29x | $24.62 Million |
| Moong Pattana International Public Company Limited (MOONG) | $736.89 Million | 17.52% | 0.30x | $6.29 Million |
| Neo Corporate Pcl (NEO) | $1.57 Billion | 52.93% | 3.65x | $52.82 Million |
| Nutrition Profess Public Company Limited (NUT) | $279.67 Million | 19.72% | 0.77x | $1.15K |